Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LENVATINIB Cause Wrong technique in product usage process? 13 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Wrong technique in product usage process have been filed in association with LENVATINIB (Lenvima). This represents 0.0% of all adverse event reports for LENVATINIB.

13
Reports of Wrong technique in product usage process with LENVATINIB
0.0%
of all LENVATINIB reports
3
Deaths
1
Hospitalizations

How Dangerous Is Wrong technique in product usage process From LENVATINIB?

Of the 13 reports, 3 (23.1%) resulted in death, 1 (7.7%) required hospitalization.

Is Wrong technique in product usage process Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LENVATINIB. However, 13 reports have been filed with the FAERS database.

What Other Side Effects Does LENVATINIB Cause?

Diarrhoea (4,262) Hypertension (4,152) Fatigue (3,603) Decreased appetite (3,257) Malignant neoplasm progression (2,929) Nausea (2,492) Blood pressure increased (2,228) Vomiting (1,962) Asthenia (1,643) Malaise (1,602)

What Other Drugs Cause Wrong technique in product usage process?

EVOLOCUMAB (21,664) ALBUTEROL (17,114) ADALIMUMAB (11,766) PEGFILGRASTIM (10,217) ETANERCEPT (9,835) ERENUMAB-AOOE (9,359) SACUBITRIL\VALSARTAN (8,022) LEUPROLIDE (5,062) FENTANYL (2,812) SEMAGLUTIDE (2,538)

Which LENVATINIB Alternatives Have Lower Wrong technique in product usage process Risk?

LENVATINIB vs LEPONEX LENVATINIB vs LERCANIDIPINE LENVATINIB vs LETAIRIS LENVATINIB vs LETERMOVIR LENVATINIB vs LETROZOLE

Related Pages

LENVATINIB Full Profile All Wrong technique in product usage process Reports All Drugs Causing Wrong technique in product usage process LENVATINIB Demographics